Publications
- Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia - Czech national study2020 | First Faculty of Medicine
- Idelalisib in the treatment of chronic lymphocytic leukaemia2015 | First Faculty of Medicine
- Prevalence of chromosomally integrated HHV-6 in patients with malignant disease and healthy donors in the Czech Republic2013 | First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Alterations of CHEK2 forkhead-associated domain increase the risk of Hodgkin lymphoma2011 | First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine
- Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients2011 | Third Faculty of Medicine, Second Faculty of Medicine
- Risk factors in chronic lymphocytic leukemia, validation of flow cytometric detection using RT-PCR and immunohistochemistry2009 | Third Faculty of Medicine
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group2023 | Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia - cardiovascular complications and bleeding2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Other malignancies in the history of CLL: an international multicenter study coducted by ERIC, the European Research Initiative on CLL, in HARMONY2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...
